Pepsi fulfills Rockstar dream
This article was originally published in The Tan Sheet
Executive Summary
The Purchase, N.Y.-based beverage giant enters a multiyear agreement to distribute Rockstar energy drink, the No. 3 brand in the category, according to Information Resources Inc. sales data for the 52 weeks ending Jan. 25 from supermarkets, drugstores and mass merchandise outlets, excluding Wal-Mart. Rockstar, made by Rockstar International, sold $99.1 million during that period and captured 11 percent market share. A number of Pepsi energy drinks in the Amp line are in the top 20, but none claim more than 4 percent of the segment. The distribution deal, the terms of which were not disclosed, "is a major milestone" in Pepsi's bid to become the energy drink category leader, Hugh Johnston, president of Pepsi-Cola North America Beverages, says Feb. 19. Industry experts say to move up in the energy drink market, large firms must pursue deals like Pepsi's with Rockstar, given the "first mover advantage" of Red Bull and Hansen Natural's Monster (1"The Tan Sheet" Sept. 8, 2008, p. 11)
You may also be interested in...
Market Experts See Energy Drink Growth Flagging, Dominant Players Reigning
Beverage industry experts foresee the explosive growth rate of the energy drink market falling to earth during the next five years, as products have virtually saturated the market and new customer segments have failed to materialize
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.